Implementation of an Absolute Brain $^{1}$H-MRS Quantification Method to Assess Different Tissue Alterations in Multiple Sclerosis
暂无分享,去创建一个
Christian Confavreux | Françoise Durand-Dubief | Dominique Sappey-Marinier | Jean-Christophe Comte | François Cotton | Matthieu Bagory | Danielle Ibarrola | D. Sappey-Marinier | C. Confavreux | F. Cotton | D. Ibarrola | J. Comte | F. Durand-Dubief | M. Bagory
[1] L. Krupp,et al. Metabolic differences between multiple sclerosis subtypes measured by quantitative MR spectroscopy , 2002, Multiple sclerosis.
[2] M. Bagory,et al. "Absolute" quantification in Magnetic Resonance Spectroscopy: validation of a clinical protocol in multiple sclerosis , 2007, 2007 29th Annual International Conference of the IEEE Engineering in Medicine and Biology Society.
[3] Klaas Nicolay,et al. 1H MR spectroscopy of the brain: absolute quantification of metabolites. , 2006, Radiology.
[4] Zografos Caramanos,et al. 1H-MRS quantification of tNA and tCr in patients with multiple sclerosis: a meta-analytic review. , 2005, Brain : a journal of neurology.
[5] C H Polman,et al. MR spectroscopic evidence for glial increase but not for neuro‐axonal damage in MS normal‐appearing white matter , 2005, Magnetic resonance in medicine.
[6] D. Arnold,et al. Choline is increased in pre-lesional normal appearing white matter in multiple sclerosis , 2002, Journal of Neurology.
[7] S. M. Steve. SUSAN - a new approach to low level image processing , 1997 .
[8] Jullie W Pan,et al. Quantitative 1H spectroscopic imaging of human brain at 4.1 T using image segmentation , 1996, Magnetic resonance in medicine.
[9] Hristian,et al. RELAPSES AND PROGRESSION OF DISABILITY IN MULTIPLE SCLEROSIS , 2000 .
[10] Alan C. Evans,et al. A nonparametric method for automatic correction of intensity nonuniformity in MRI data , 1998, IEEE Transactions on Medical Imaging.
[11] D. Graveron-Demilly,et al. Java-based graphical user interface for the MRUI quantitation package , 2001, Magnetic Resonance Materials in Physics, Biology and Medicine.
[12] R I Grossman,et al. Total brain N-acetylaspartate , 2000, Neurology.
[13] M. Sdika,et al. Time‐domain semi‐parametric estimation based on a metabolite basis set , 2005, NMR in biomedicine.
[14] J. Frahm,et al. Inflammatory CNS demyelination: histopathologic correlation with in vivo quantitative proton MR spectroscopy. , 1999, AJNR. American journal of neuroradiology.
[15] Oded Gonen,et al. Diffusely elevated cerebral choline and creatine in relapsing‐remitting multiple sclerosis , 2003, Magnetic resonance in medicine.
[16] Antonio Federico,et al. Magnetic resonance spectroscopy as a measure of brain damage in multiple sclerosis , 2005, Journal of the Neurological Sciences.
[17] D. Leibfritz,et al. Multinuclear NMR studies on the energy metabolism of glial and neuronal cells. , 1993, Developmental neuroscience.
[18] U Klose,et al. Proton MR spectroscopy with metabolite-nulling reveals elevated macromolecules in acute multiple sclerosis. , 2001, Brain : a journal of neurology.
[19] R. Kreis. Quantitative localized 1H MR spectroscopy for clinical use , 1997 .
[20] Zografos Caramanos,et al. Axonal metabolic recovery in multiple sclerosis patients treated with interferon β–1b , 2001, Journal of Neurology.
[21] P M Matthews,et al. Evidence of axonal damage in the early stages of multiple sclerosis and its relevance to disability. , 2001, Archives of neurology.
[22] C. Elster,et al. Serial 1H-MRS in relapsing-remitting multiple sclerosis: effects of interferon-β therapy on absolute metabolite concentrations , 2002, Magnetic Resonance Materials in Physics, Biology and Medicine.
[23] P. Narayana,et al. Compensation for surface coil sensitivity variation in magnetic resonance imaging. , 1988, Magnetic resonance imaging.
[24] O. Khan,et al. Long‐Term Study of Brain 1H‐MRS Study in Multiple Sclerosis: Effect of Glatiramer Acetate Therapy on Axonal Metabolic Function and Feasibility of Long‐Term 1H‐MRS Monitoring in Multiple Sclerosis , 2008, Journal of neuroimaging : official journal of the American Society of Neuroimaging.
[25] J. Babb,et al. Relapsing-remitting multiple sclerosis and whole-brain N-acetylaspartate measurement: evidence for different clinical cohorts initial observations. , 2002, Radiology.
[26] Stephen K Fisher,et al. Inositol and higher inositol phosphates in neural tissues: homeostasis, metabolism and functional significance , 2002, Journal of neurochemistry.
[27] L L Wald,et al. Proton spectroscopic imaging of the human brain using phased array detectors , 1995, Magnetic resonance in medicine.
[28] P. Kingsley,et al. Saturation‐corrected T 1 and T 2 relaxation times of choline, creatine and N‐acetyl aspartate in human cerebral white matter at 1.5 T , 2003, NMR in biomedicine.
[29] Gregor Jost,et al. Quantitative single‐voxel spectroscopy: The reciprocity principle for receive‐only head coils , 2005, Journal of magnetic resonance imaging : JMRI.
[30] André Briguet,et al. Product-Operator Algebra for Strongly Coupled Spin Systems , 1993 .
[31] Stephen M. Smith,et al. Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm , 2001, IEEE Transactions on Medical Imaging.
[32] P. Roemer,et al. The NMR phased array , 1990, Magnetic resonance in medicine.
[33] G Helms,et al. Volume correction for edema in single‐volume proton MR spectroscopy of contrast‐enhancing multiple sclerosis lesions , 2001, Magnetic resonance in medicine.
[34] G J Barker,et al. Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions. , 1994, Brain : a journal of neurology.
[35] Oded Gonen,et al. Metabolite ratios to assumed stable creatine level may confound the quantification of proton brain MR spectroscopy. , 2003, Magnetic resonance imaging.
[36] H. Rusinek,et al. MR spectroscopy indicates diffuse multiple sclerosis activity during remission , 2009, Journal of Neurology, Neurosurgery & Psychiatry.
[37] A. Evans,et al. MRI simulation-based evaluation of image-processing and classification methods , 1999, IEEE Transactions on Medical Imaging.
[38] S. Vukusic,et al. Natural history of multiple sclerosis: a unifying concept. , 2006, Brain : a journal of neurology.
[39] A. Thompson,et al. Elevated white matter myo-inositol in clinically isolated syndromes suggestive of multiple sclerosis. , 2004, Brain : a journal of neurology.
[40] D. Gadian,et al. Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[41] Michael Erb,et al. Comparison of longitudinal metabolite relaxation times in different regions of the human brain at 1.5 and 3 Tesla , 2003, Magnetic resonance in medicine.
[42] D. Louis Collins,et al. Design and construction of a realistic digital brain phantom , 1998, IEEE Transactions on Medical Imaging.
[43] S. Confort-Gouny,et al. Optimization of residual water signal removal by HLSVD on simulated short echo time proton MR spectra of the human brain. , 2001, Journal of magnetic resonance.
[44] B. Agranoff,et al. Differentiated Human NT2‐N Neurons Possess a High Intracellular Content of myo‐Inositol , 1999, Journal of neurochemistry.
[45] Yoshio Hiraki,et al. Development of a tissue‐equivalent MRI phantom using carrageenan gel , 2003, Magnetic resonance in medicine.
[46] F. Barkhof. The clinico‐radiological paradox in multiple sclerosis revisited , 2002, Current opinion in neurology.
[47] Stephen M Smith,et al. Fast robust automated brain extraction , 2002, Human brain mapping.
[48] P M Matthews,et al. Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis. Results of a longitudinal magnetic resonance spectroscopy study. , 1998, Brain : a journal of neurology.
[49] J. Frahm,et al. Absolute concentrations of metabolites in the adult human brain in vivo: quantification of localized proton MR spectra. , 1993, Radiology.